106670-34-2

Basic information

• Product Name: 2-[(4-METHYLBENZYL)THIO]ETHANAMINE
• Synonyms: EthanaMine,2-[[(4-Methylphenyl)Methyl]thio]-;{2-[(4-methylbenzyl)thio]ethyl}amine;2-[(4-methylbenzyl)thio]ethylamine;2-[(4-methylphenyl)methylsulfanyl]ethanamine;2-[(4-methylphenyl)methylthio]ethanamine
• CAS NO: 106670-34-2
• Molecular Formula: C₁₀H₁₅NS
• Molecular Weight: 181.3
• Mol File: 106670-34-2.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 289.7 °C at 760 mmHg
• Flash Point: 129 °C
• Appearance: /
• Density: 1.049 g/cm³
• Vapor Pressure: 0.00217mmHg at 25°C
• CAS DataBase Reference: 2-[(4-METHYLBENZYL)THIO]ETHANAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[(4-METHYLBENZYL)THIO]ETHANAMINE(106670-34-2)
• EPA Substance Registry System: 2-[(4-METHYLBENZYL)THIO]ETHANAMINE(106670-34-2)

Safety Data

• Hazardous Substances Data: 106670-34-2(Hazardous Substances Data)

Usage

General Description

"2-[(4-Methylbenzyl)thio]ethanamine" is a chemical compound that consists of a thiol group attached to a benzyl group, which in turn is linked to an ethylamine moiety. It is also known as N-(4-methylbenzyl)ethanethioamide. 2-[(4-METHYLBENZYL)THIO]ETHANAMINE has potential applications in organic synthesis and pharmaceutical research due to its ability to participate in various chemical reactions such as substitution and addition. Additionally, it may have biological activity and could be studied for its potential medicinal properties. However, it should be handled and utilized with caution, as with any chemical substance.

InChI:InChI=1/C10H15NS/c1-9-2-4-10(5-3-9)8-12-7-6-11/h2-5H,6-8,11H2,1H3/p+1

Upstream product

• 60-23-1 Cysteamine 
• 104-82-5 4-Methylbenzyl chloride 
• 156-57-0 2-mercaptoethylamine hydrochloride 

Downstream Products

• 537678-34-5 C₂₀H₁₉NO₂S₂ 
• 537678-34-5 C₂₀H₁₉NO₂S₂ 
• 106668-72-8 N-[3-(1H-Imidazol-4-yl)-propyl]-N'-[2-(4-methyl-benzylsulfanyl)-ethyl]-guanidine; hydrochloride 

Relevant articles and documents

Enantioselective Synthesis of N,S-Acetals by an Oxidative Pummerer-Type Transformation using Phase-Transfer Catalysis

Reported is the first enantioselective oxidative Pummerer-type transformation using phase-transfer catalysis to deliver enantioenriched sulfur-bearing heterocycles. This reaction includes the direct oxidation of sulfides to a thionium intermediate, followed by an asymmetric intramolecular nucleophilic addition to form chiral cyclic N,S-acetals with moderate to high enantioselectivites. Deuterium-labelling experiments were performed to identify the stereodiscrimination step of this process. Further analysis of the reaction transition states, by means of multidimensional correlations and DFT calculations, highlight the existence of a set of weak noncovalent interactions between the catalyst and substrate that govern the enantioselectivity of the reaction.

IMIDAZOLYL ALKYL GUANIDINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS

New imidazolylalkyl-guanidine derivatives are described, which by virtue of their agonistic action on histamine-H 2 receptors and in part also due to their additional H 1-antagonistic receptor activity can be used in the treatment of cardiac diseases, certain forms of hypertension and diseases of arterial occlusion.These imidazolylalkyl-guanidine derivatives correspond to the general formula I: STR1